1. Abood, L. G., and Biel, J. H., 1962, Anticholinergic psychotomimetic agents, Int. Rev. Neurobiol. 6: 218–273.
2. Abood, L. G., and Meduna, L. J., 1958, Some effects of a new psychotogen in depressive states, J. Nerv. Ment. Dis. 127: 546–550.
3. Ananth, J. V., Horodesky, S., Lehmann, H. E., and Ban, T. A., 1970, Effect of withdrawal of antiparkinsonian medication of chronical ly hospitalized psychiatric patients, Laval Medical 41: 934–938.
4. Ayd, F. J., 1961, Neuroleptic and extrapyramidal reactions in psychiatric patients, in “Extrapyramidal System,” J. M. Bordeleau, ed., pp. 355–365 Editions Psychiatrique, Montreal.
5. Bignami, C., Rosic, N., Michalek, H., Milosevic, M., and Gatti, G. L. 1975, Behavioral toxicity of anticholinesterase agents: Methodological, neurochemical and neuropsychological aspects, in “Behavoral Toxicity,” B. Weiss and V. G. Laties, eds., pp. 155–215, Plenum Press, New York.